Aridis pharmaceuticals announces 2020 fourth quarter and year-end financial results and business update

Los gatos, calif., march 30, 2021 /prnewswire/ -- aridis pharmaceuticals, inc. (nasdaq: ards), a biopharmaceutical company focused on the discovery and development of novel anti-infective therapies to treat life-threatening infections, today reported financial and corporate results for the fourth quarter ended december 31, 2020.
ARDS Ratings Summary
ARDS Quant Ranking